306 related articles for article (PubMed ID: 24145533)
21. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
[TBL] [Abstract][Full Text] [Related]
23. Novel dengue virus NS2B/NS3 protease inhibitors.
Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
25. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
26. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
27. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
28. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1.
Rothan HA; Han HC; Ramasamy TS; Othman S; Rahman NA; Yusof R
BMC Infect Dis; 2012 Nov; 12():314. PubMed ID: 23171075
[TBL] [Abstract][Full Text] [Related]
30. Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.
Byrd CM; Grosenbach DW; Berhanu A; Dai D; Jones KF; Cardwell KB; Schneider C; Yang G; Tyavanagimatt S; Harver C; Wineinger KA; Page J; Stavale E; Stone MA; Fuller KP; Lovejoy C; Leeds JM; Hruby DE; Jordan R
Antimicrob Agents Chemother; 2013 Apr; 57(4):1902-12. PubMed ID: 23403421
[TBL] [Abstract][Full Text] [Related]
31. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of dengue virus by targeting viral NS4B protein.
Xie X; Wang QY; Xu HY; Qing M; Kramer L; Yuan Z; Shi PY
J Virol; 2011 Nov; 85(21):11183-95. PubMed ID: 21865382
[TBL] [Abstract][Full Text] [Related]
34. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.
Hishiki T; Kato F; Nio Y; Watanabe S; Wen Tan NW; Yamane D; Miyazaki Y; Lin CC; Suzuki R; Tajima S; Lim CK; Saijo M; Hijikata M; Vasudevan SG; Takasaki T
Antiviral Res; 2019 May; 165():42-46. PubMed ID: 30853381
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
[TBL] [Abstract][Full Text] [Related]
37. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S
Virol J; 2015 Feb; 12():16. PubMed ID: 25886260
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 protease.
Lin CS; Lu CH; Lin TH; Kiu YT; Kan JY; Chang YJ; Hung PY; Koval'skaya AV; Tsypyshev DO; Tsypysheva IP; Lin CW
Bioorg Med Chem Lett; 2024 Feb; 99():129623. PubMed ID: 38242331
[TBL] [Abstract][Full Text] [Related]
39. Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors.
Weng Z; Shao X; Graf D; Wang C; Klein CD; Wang J; Zhou GC
Eur J Med Chem; 2017 Jan; 125():751-759. PubMed ID: 27721158
[TBL] [Abstract][Full Text] [Related]
40. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
Kato F; Hishiki T
Viruses; 2016 May; 8(5):. PubMed ID: 27164125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
